Evolution and cell biology of dopamine receptors in vertebrates

被引:156
作者
Callier, S [1 ]
Snapyan, M [1 ]
Le Crom, S [1 ]
Prou, D [1 ]
Vincent, JD [1 ]
Vernier, P [1 ]
机构
[1] CNRS, Inst Neurobiol Alfred Fessard, UPR 2197, DEPSN, F-91198 Gif Sur Yvette, France
关键词
receptor trafficking; phylogeny; desensitization; cell signalling; oligomerization;
D O I
10.1016/S0248-4900(03)00089-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dopamine, one of main modulatory neurotransmitters of the nervous system acts on target cells through two classes of G protein-coupled receptors, D-1 and D-2 The two dopamine receptor classes display different structures, interact with different regulatory partners (including heterotrimeric G proteins) and, accordingly, have independent evolutionary origins. In vertebrates, each of these receptor classes comprises several subtypes, generated by two steps of gene duplications, early in vertebrate evolution. In the D-1 receptor class, the D-1A, D-1B, D-1C and D-1D subtypes, and in the D-2 class, the D-2, D-3 et D-4 receptor subtypes have been conserved in most vertebrate groups. This conservation has been driven by the acquisition, by each receptor subtype, of a small number of specific properties, which were selected for adaptive purpose in vertebrates. Among these properties, affinity for dopamine, the natural ligand, intrinsic receptor activity, and agonist-induced desensitization clearly distinguish the receptor subtypes. In addition, each dopamine receptor subtype is addressed to a specific location within neuronal networks, although detailed information is lacking for several receptor subtypes. Receptors localization at diverse subcellular places in neurons may also differ from one subtype to another, resulting in different ways of regulating cell signalisation. One challenge for future research on dopamine and its receptors would be to identify the nature of the protein partners and the molecular mechanisms involved in localizing receptors to the neuronal plasma membrane. In this respect, the evolutionary approach we have undertaken suggests that, due to gene duplications, a reasonable degree of freedom exists in the tight organisation of dopamine receptors in neurons. This "evolvability" of dopamine systems has been instrumental to adapt the vertebrate species to nearly all the possible environments. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:489 / 502
页数:14
相关论文
共 93 条
[1]   Vertebrate evolution - recent perspectives from fish [J].
Aparicio, S .
TRENDS IN GENETICS, 2000, 16 (02) :54-56
[2]  
BARTON AC, 1991, MOL PHARMACOL, V39, P650
[3]  
Bergson C, 1995, J NEUROSCI, V15, P7821
[4]   Interaction of γ-COP with a transport motif in the D1 receptor C-terminus [J].
Bermak, JC ;
Li, M ;
Bullock, C ;
Weingarten, P ;
Zhou, QY .
EUROPEAN JOURNAL OF CELL BIOLOGY, 2002, 81 (02) :77-85
[5]   Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein [J].
Bermak, JC ;
Li, M ;
Bullock, C ;
Zhou, QY .
NATURE CELL BIOLOGY, 2001, 3 (05) :492-498
[6]   D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N [J].
Binda, AV ;
Kabbani, N ;
Lin, RW ;
Levenson, R .
MOLECULAR PHARMACOLOGY, 2002, 62 (03) :507-513
[7]   Early emergence of three dopamine D-1 receptor subtypes in vertebrates - Molecular phylogenetic, pharmacological, and functional criteria defining D-1A, D-1B, and D-1C receptors in European eel Anguilla anguilla [J].
Cardinaud, B ;
Sugamori, KS ;
Coudouel, S ;
Vincent, JD ;
Niznik, HB ;
Vernier, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) :2778-2787
[8]   Human dopamine D3 receptors mediate mitogen- activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism [J].
Cussac, D ;
Newman-Tancredi, A ;
Pasteau, V ;
Millan, MJ .
MOLECULAR PHARMACOLOGY, 1999, 56 (05) :1025-1030
[9]   THE DOPAMINE D1D RECEPTOR - CLONING AND CHARACTERIZATION OF 3 PHARMACOLOGICALLY DISTINCT D1-LIKE RECEPTORS FROM GALLUS-DOMESTICUS [J].
DEMCHYSHYN, LL ;
SUGAMORI, KS ;
LEE, FJS ;
HAMADANIZADEH, SA ;
NIZNIK, HB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) :4005-4012
[10]  
FILTZ TM, 1993, MOL PHARMACOL, V44, P371